IV infusion reactions in critical care

0

Intravenous news: UPI.com report “German researchers suggest some infusion solutions in a common intravenous treatment may cause life-threatening inflammation. The study, published in the Journal of Leukocyte Biology, found a common intravenous treatment used to boost blood pressure in critical patients contains substances called “advanced glycation end products.” This reaction among various proteins occurring after the fluid has been formulated for use is called “post-translational modification.” The researchers suggest screening infusion solutions for post-translational protein modifications and then removing the compounds.”

Click here to read the full story on UPI.com

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.